Clinical Pharmacology for Development of Topical Dermatological Products: Present and Future Opportunities for Safety and Efficacy

被引：3
|
作者：
Cho, S. [1 ]
Bashaw, E. D. [1 ]
机构：
[1] US FDA, Off Clin Pharmacol, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷 / 02期
关键词：
D O I：
10.1038/clpt.2010.283
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The development of topical products for dermatological diseases represents an untapped opportunity for the clinical pharmacologist. Assessment of bioavailability of topical drugs and its utility in weighing benefit vs. risk has been unique and challenging, compared with assessments for conventional systemic drugs. However, with continued advances in analytical methods and growing interests in discovering biomarkers, the future opportunities for clinical pharmacology to advance topical drug development processes are enormous and will be limited only by our drive and determination to push science forward.
引用
收藏
页码：167 / 169
页数：3
相关论文
共 50 条
12345